Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifestyle intervention improves cognition and quality of life in persons with early Multiple Sclerosis.

Multiple sclerosis and related disorders·2024
Same author

Editorial: Diet and multiple sclerosis.

Frontiers in neurology·2023
Same author

Neuro-Advocacy-Professionalism in Action.

JAMA neurology·2021
Same author

Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update.

Neurology·2019
Same author

Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers.

Multiple sclerosis and related disorders·2019
Same author

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

The New England journal of medicine·2018

Related Experiment Video

Updated: Jun 3, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Diagnosis of multiple sclerosis.

Barbara S Giesser1

  • 1Department of Neurology, David Geffen University of California, Los Angeles School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90095, USA. bgiesser@mednet.ucla.edu

Neurologic Clinics
|March 29, 2011
PubMed
Summary

Diagnosing multiple sclerosis (MS) relies on clinical assessment, not a single definitive test. Recent guidelines integrate clinical, radiological, and paraclinical data for accurate MS diagnosis.

Area of Science:

  • Neurology
  • Clinical Diagnostics

Background:

  • Multiple sclerosis (MS) diagnosis is primarily clinical due to the absence of a pathognomonic indicator.
  • Historically, MS diagnosis has sometimes been considered a diagnosis of exclusion.

Purpose of the Study:

  • To present updated guidelines for diagnosing multiple sclerosis.
  • To outline the integration of clinical, radiological, and paraclinical findings.
  • To identify red flags necessitating alternative diagnostic considerations.

Main Methods:

  • Review of recent diagnostic guidelines for multiple sclerosis.
  • Analysis of clinical, radiological, and paraclinical evidence.
  • Identification of warning signs for differential diagnoses.

Main Results:

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

  • Current diagnostic approaches for MS are increasingly objective.
  • Sophisticated guidelines and paraclinical data enable confident diagnosis confirmation or exclusion.
  • Specific red flags guide clinicians toward considering other conditions.

Conclusions:

  • Multiple sclerosis diagnosis is a refined clinical judgment supported by objective data.
  • Adherence to current guidelines ensures accurate and timely MS diagnosis.
  • Awareness of red flags is crucial for differential diagnosis in suspected MS cases.